About: Compugen (Israeli company)

An Entity of Type: Public company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Compugen Ltd. (Hebrew: קומפיוג'ן) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big pharmas such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and are among Compugen's competi

thumbnail
Property Value
dbo:abstract
  • Compugen Ltd. (Hebrew: קומפיוג'ן) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big pharmas such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and are among Compugen's competitors. (en)
dbo:foundingYear
  • 1993-01-01 (xsd:gYear)
dbo:industry
dbo:keyPerson
dbo:netIncome
  • -8500000.0
dbo:operatingIncome
  • -8700000.0
dbo:revenue
  • 53000.0
dbo:thumbnail
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 34046261 (xsd:integer)
dbo:wikiPageLength
  • 18324 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1110509234 (xsd:integer)
dbo:wikiPageWikiLink
dbp:founder
  • Amir Natan (en)
  • Eli Mintz (en)
  • Simchon Faigler (en)
dbp:industry
dbp:keyPeople
dbp:locationCity
dbp:locationCountry
dbp:logo
  • Compugen logo.gif (en)
dbp:name
  • Compugen (en)
  • Compugen Ltd. (en)
dbp:netIncome
  • US$ -8.5 million () (en)
dbp:operatingIncome
  • US$ -8.7 million () (en)
dbp:revenue
  • US$ 53 thousand () (en)
dbp:secCik
  • 1119774 (xsd:integer)
dbp:symbol
  • CGEN (en)
dbp:tradedAs
  • NASDAQ:CGEN (en)
dbp:type
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Compugen Ltd. (Hebrew: קומפיוג'ן) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big pharmas such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and are among Compugen's competi (en)
rdfs:label
  • Compugen (Israeli company) (en)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
foaf:name
  • Compugen Ltd. (en)
is dbo:wikiPageDisambiguates of
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License